Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
7h
Study Finds on MSNDangerous bacteria lurking in hospital drains survive aggressive cleaning protocolsIn a nutshell A year-long study of hospital sink drains found 67 different bacterial species living there, many resistant to ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
Belgium’s Deputy Prime Minister, Frank Vandenbroucke, called the EU’s joint health technology assessment a model of European cooperation, improving medicine evaluation, reducing costs, and ...
The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
Maternal acetaminophen exposure during pregnancy is associated with a higher likelihood of childhood attention deficit ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
LETHBRIDGE [email protected] The Lethbridge & District Exhibition’s financial deficit was lower than anticipated at the end of its fiscal year. Acting CEO Kim Gallucci’s report to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results